Journal List > Ann Lab Med > v.38(2) > 1091584

Sung, Hwang, Shin, Park, Lee, Yong, and Lee: Utility of Conventional Culture and MALDI-TOF MS for Identification of Microbial Communities in Bronchoalveolar Lavage Fluid in Comparison with the GS Junior Next Generation Sequencing System

Abstract

Background

Diverse microbiota exist in the lower respiratory tract. Although next generation sequencing (NGS) is the most widely used microbiome analysis technique, it is difficult to implement NGS in clinical microbiology laboratories. Therefore, we evaluated the performance of conventional culture methods together with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in identifying microbiota in bronchoalveolar lavage (BAL) fluid.

Methods

BAL fluid samples (n=27) were obtained from patients undergoing diagnostic bronchoscopy for lung mass evaluation. Bacterial and fungal culture was performed with conventional media used in clinical microbiology laboratories. On an average, 20 isolated colonies were picked from each agar plate and identified by MALDI-TOF MS. Microbiome analysis using 16S rRNA NGS was conducted for comparison.

Results

Streptococcus spp. and Neisseria spp. were most frequently cultured from the BAL fluid samples. In two samples, Enterobacteriaceae grew predominantly on MacConkey agar. Actinomyces and Veillonella spp. were commonly identified anaerobes; gut bacteria, such as Lactobacillus, Bifidobacterium, and Clostridium, and fungi were also isolated. NGS revealed more diverse bacterial communities than culture, and Prevotella spp. were mainly identified solely by NGS. Some bacteria, such as Staphylococcus spp., Clostridium spp., and Bifidobacterium spp., were identified solely by culture, indicating that culture may be more sensitive for detecting certain bacteria.

Conclusions

Culture and NGS of BAL fluid samples revealed common bacteria with some different microbial communities. Despite some limitations, culture combined with MALDI-TOF MS might play a complementary role in microbiome analysis using 16S rRNA NGS.

INTRODUCTION

Increasing data have demonstrated that colonizing microorganisms might dictate human health and disease [1]. Although the 2012 Human Microbiome Project did not include the lower respiratory tract in its surveys, advances in sequencing technology have revealed a diverse population of non-routinely cultured bacteria in the lung, which has traditionally been thought to be sterile [2345]. Most of these studies are based on 16S rRNA next generation sequencing (NGS), a highly sensitive method for analyzing the microbiome [6]. Because the human microbiota consists of many ‘unculturable’ bacteria, culture-independent metagenomic approaches have driven significant advances in microbiome research. However, the bacterial species information obtainable from these metagenomic approaches might be limited, and there are several steps, including nucleic acid extraction, PCR amplification, sequencing (method and depth), and bioinformatic analysis, that may produce variations in the results. Read length is also one of the most important factors when considering clinical application. Hence, the cultivation of microbes provides more reliable information regarding the phenotype and ecological role, allowing a greater understanding of microbe-host interactions [7].
Recently, a number of new approaches for gut microbiota cultivation have emerged with potential for use in microbiome research [8]; these have mainly been applied to investigate the gut microbiome [91011]. Although these novel approaches have shown that culture can capture a significant subset of the species identified using culture-independent methods [8], it is not easy to apply these techniques in clinical laboratories. In addition, limited information is available regarding culture-based microbiome analysis of the respiratory tract compared with that of the gut. We used culture conditions commonly adopted in conventional clinical microbiology laboratories to explore the micro-biota in bronchoalveolar lavage (BAL) fluid compared with the microbiome results obtained via 16S rRNA NGS.

METHODS

1. Sample collection

BAL fluid samples were collected from patients undergoing bronchoscopy procedures for lung mass evaluation at Severance Hospital, Seoul, Korea from May to November 2015. The bronchoscope was inserted through the mouth, and BAL was collected according to a standardized protocol at the opposite side of the lung mass; 10 mL BAL fluid was acquired from the patients with approximately 30 mL sterile 0.9% saline. Sample was collected in accordance with the Institutional Review Board of Severance Hospital (IRB No. 4-2014-1014); informed consent was obtained from the patients.

2. Culture conditions

BAL fluid samples were cultured on the day within 6 hours of collection. Undiluted BAL fluid (100 µL) was inoculated onto an agar plate using a spreader. Different agar plates with aerobic and anaerobic conditions were used: blood agar (aerobic, 35℃, 5% CO2), chocolate agar (aerobic, 35℃, 5% CO2), MacConkey agar (aerobic, 35℃, 5% CO2), Brucella agar (anaerobic, 35℃), phenylethyl alcohol agar (anaerobic, 35℃), and Sabouraud dextrose agar (aerobic, 30℃, ambient air). Bacterial colonies were isolated after 48 hours of culture. Sabouraud dextrose agar (SDA) plates used for fungal culture were observed for up to four weeks of incubation.

3. Bacterial identification

An average of 20 colonies with different morphologies and sizes were selected from each agar plate and applied to a Microflex LT matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) system with Biotyper software 3.1 (Bruker Daltonics, Bremen, Germany) for simultaneous identification and subculture. When an accurate identification was not available (score <1.7) using only α-cyano-4-hydroxycinnamic acid, formic acid was added. Strains that could not be reliably identified by MALDI-TOF MS were subjected to further analysis; the subcultured colonies were analyzed using 16S rRNA sequencing for bacteria and ITS sequencing for fungi performed with primers 27F-1492R and ITS4, respectively (Table 1). To detect Staphylococcus spp., Klebsiella spp., and Enterobacter spp. in samples from which bacterial species were isolated solely on culture plates, we performed PCR amplification using organism-specific primers as previously described [121314] (Table 1).

4. High-throughput sequencing

DNA was extracted from BAL fluid within 6 hours of sample collection by using the DNeasy Blood & Tissue kit (Qiagen, Venlo, Limburg, Netherlands), according to the manufacturer's protocol. DNA extraction was performed simultaneously with bacterial culture. The DNA samples were stored at –70℃ until further analysis. The 16S rRNA gene from each DNA sample was amplified using barcoded fusion primers targeting the V1 to V3 regions (27F-518R), because this region has been reported to be reliable for accurate taxonomic classification of bacterial sequences [15] (Table 1). Amplification was carried out under the following conditions: initial denaturation at 95℃ for 5 minutes; followed by 30 cycles of denaturation at 95℃ for 30 seconds, primer annealing at 55℃ for 30 seconds, and extension at 72℃ for 30 seconds; and a final elongation step at 72℃ for 7 minutes. PCR products were confirmed using 2% agarose gel electrophoresis and visualized with a Gel Doc system (BioRad, Hercules, CA, USA). The amplified products were purified using the QIA-quick PCR purification kit (Qiagen). Equal concentrations of purified products were pooled together, and short fragments (non-target products) were removed using the AMPure beads kit (Agencourt Bioscience, Beverly, MA, USA). Quality and product size were assessed on a Bioanalyzer 2100 (Agilent, Palo Alto, CA, USA) using a DNA 7500 chip. Mixed amplicons were obtained by emulsion PCR and then deposited on picotiter plates. Sequencing was carried out at Chunlab, Inc. (Seoul, Korea) using the GS Junior Sequencing system (Roche, Branford, CT, USA) according to the manufacturer's instructions. Reads obtained from different samples were sorted using the unique barcodes on each PCR product. The barcode, linker, and primer sequences were removed from the original sequencing reads. Any reads containing two or more ambiguous nucleotides, low-quality score (average score <25), or reads shorter than 300 bp were discarded. Potential chimera sequences were detected using the UCHIME algorithm [16]. Following removal of the chimera sequences, the taxonomic classification of each read was assigned against the EzTaxon-e database (http://eztaxon-e.ezbiocloud.net) [17].
The operational taxonomic units (OTUs) identified at the genus level were listed with the number of reads, reflecting the relative frequency of detection. Next, the number of cultured colonies was compared with the number of OTUs determined by NGS in the same sample to analyze the difference in identification by NGS and culture.

RESULTS

1. Culture and MALDI-TOF MS identification

A total of 2,272 microbial colonies were isolated from 27 BAL fluid samples and identified using culture and MALDI-TOF MS. The number of genera identified per sample ranged from 4 to 14, with an average of 8. The total number of genera identified was 29; these included 85 species. Streptococcus spp. were the predominant isolates with a total number of 1,213 colonies (Table 2). Culture on blood and MacConkey agar resulted in the highest and the lowest number of microorganisms, respectively. Forty (1.76%, 40/2,272) colonies were not identified by MALDI-TOF MS. These colonies were subcultured and re-identified using MALDI-TOF MS with the aid of formic acid, yielding mainly Streptococcus spp. (47.5%, 19/40). Four colonies (0.18%, 4/2,272) could not be identified with repeated MALDI-TOF MS; these were identified as Actinomyces odontolyticus, Actinomyces gravenitzii, Fusobacterium periodonticum, and Aspergillus fumigatus by sequencing using 16S rRNA and ITS gene amplification.

2. 16S rRNA NGS identification

Sequencing using the GS Junior Sequencing system generated 10,332 valid reads per sample on average (range 6,761–19,764). At the genus level, a total of 288 OTUs were identified with a mean of 55.8 (range 27–78) per sample. Considering those with a relative abundance greater than 1%, the mean number of OTUs identified at the genus level was 10.0 (range 6–17) per sample (Fig. 1), which is comparable to the number of bacterial genera identified using conventional culture and MALDI-TOF MS. Prevotella spp. was the most frequent and abundant OTU identified at the genus level; it was identified in all 27 samples (relative abundance 6.5–54.5% with a mean of 29.2%). The next most prevalent OTUs (mean relative abundance) were Streptococcus (11.5%), Neisseria (10.5%), Haemophilus (10.1%), and Veillonella (9.1%).

3. Comparison of microbial identification using culture and MALDI-TOF MS vs NGS

NGS revealed more OTUs compared with the number of genera identified by culture (Fig. 1). The relative abundance of bacterial reads identified simultaneously by culture was 47.1% on average, ranging from 3.2% to 88.0% in the 27 samples. The bacteria present in BAL fluids according to the identification method (NGS, culture, or both) are shown in Fig. 2. Of the 156 bacterial genera identified solely by NGS with >1% relative abundance, Prevotella spp. was the most common (14.1%) and frequent (22 of 27 samples, 81.5%) genus. When considered as relative abundance, the genus Prevotella spp. comprised over 50% of the bacteria that were sequenced but not cultured. Interestingly, some bacteria were identified solely by culture; of these, Staphylococcus spp., Clostridium spp., and Enterobacteriaceae including Klebsiella spp. were common, comprising 66.7% (18/27) of the 27 samples and 56.4% (22/39) of the total number of colonies that were cultured but not sequenced (Table 3). We per-formed organism-specific PCR using the primers detailed in Table 1 to detect Staphylococcus spp., Klebsiella spp., and Enterobacter spp. All PCRs failed to amplify the target organisms in the samples, suggesting DNA instability in clinical samples. Candida and Aspergillus spp. were only cultured because they cannot be identified by 16S rRNA PCR.

DISCUSSION

The purpose of this study was to evaluate the ability of the standard culture identification method used in clinical microbiology laboratories to elucidate microbial community profiles in BAL fluids. We compared the BAL fluid microbiota profiles identified by two methods: culture with MALDI-TOF MS and NGS. As expected, we failed to detect many strict anaerobic bacteria with the culture method. The most common bacteria identified solely by 16S rRNA NGS were Prevotella spp., which are abundant in respiratory specimens [18]. In a previous study, Prevotella spp. were the most abundant OTUs in BAL fluid followed by Streptococcus spp. and Neisseria spp. [19]. Prevotella spp. were isolated on Brucella or PE agar in only five samples, although sequencing identified this genus in all 27 samples. Interestingly, positive correlations between bacterial spp. and culture media were noted. For example, Streptococcus spp. grew prominently in chocolate agar under 5% CO2, and Brucella agar under anaerobic conditions. In addition, it is difficult to determine whether some of the OTUs detected solely by NGS might be contaminants [20].
Other bacteria that could not be cultured included many anaerobes such as Porphyromonas spp. and Leptotrichia spp. Failure of anaerobic culture is the most likely reason, although the viability of the sequenced bacteria without growth in culture media must be considered. It is interesting that despite the limitations of the culture conditions adopted in this study, some bacterial species, including Staphylococcus spp., Clostridium spp., and Bifidobacterium spp. were cultured, but not sequenced. Selective media (MacConkey agar and PE agar) and enriched media (chocolate and Brucella agar) were successful in identifying bacteria that were not detected using NGS. We hypothesize that culture can be more sensitive than sequencing in terms of detection under certain conditions and for some bacterial species, as shown in previous studies for Staphylococcus aureus [10] and Bifidobacterium spp. [21]. We assume that the bacteria identified solely by culture existed in very low quantities and thus failed to be sequenced. Another possible explanation is that the growth of some bacteria may be affected by culture media in association with other co-existing bacteria. The use of mixed culture via co-cultivation with helper strains could be used to facilitate growth [22 23]. As previously reported, the information provided by metagenomic approaches can be limited [24]. Many pre-analytical, analytical, and post-analytical factors can affect the outcome. DNA extraction is another step that can influence sequencing results [252627]. DNA isolation methods, the 16S rRNA target region used for PCR, and sequencing vary widely, and differences in techniques and manufacturers' kits may produce disparate data [28]. In this study, the V1-V3 region (27F-518R) of the 16S rRNA gene was amplified, because it is one of the most reliable targets for taxonomy. However, a sequencing depth of 10,332 valid reads per sample on average could affect the identification results. In addition, the culture method enabled the identification of fungi, such as Candida and Aspergillus, which cannot be detected by 16S rRNA sequencing.
It is known that a large proportion of the microbes found in the human gastrointestinal tract are unculturable [29 30], although this has been challenged by recent studies revealing many rare microorganisms. Metagenomics by deep sequencing is undoubtedly a powerful tool in microbial community analysis; however, it possesses some limitations. Sequenced DNA is not evidence of viable bacteria, and detection sensitivity is dependent on sequencing depth, which may result in a failure to identify low-abundance bacterial species. NGS approaches, especially those based on amplification of the highly conserved 16S rRNA gene, are inherently incapable of detecting intra-species variations [24]. Cultivation of microbes provides a greater understanding of bacterial interactions and traits and can be used to obtain completely sequenced genomes from these species. In addition, currently, the culture method with MALDI-TOF MS has advantages over NGS, in terms of cost and practical application. Although NGS has reduced the cost of sequencing greatly, it is still a fairly expensive technology and requires bioinformatic tools for analysis.
Recent efforts in developing culture methods have enabled the culture of previously ‘as-yet uncultured’ bacteria, known as culturomics [10, 3132]. The use of several different culture conditions has enabled the isolation of new bacterial species, the largest human virus, the largest bacterium, and the largest archaeon from humans [33]. One study demonstrated that analyses of the same samples produced only partially overlapping results; 51 of the 340 species and 698 phylotypes were identified by culturomics and metagenomic analysis, respectively [10]. However, various culture conditions, including many nonselective and selective culture media used in culturomics, are not practical for application in conventional clinical microbiology laboratories. MALDI-TOF MS is another powerful tool used in microbial identification. MALDI-TOF MS has allowed for the accurate identification of a large panel of anaerobes that are poorly identified because of ambiguous or erroneous results using conventional methods. Coupling MALDI-TOF MS with culturomics has enabled the identification of a large collection of bacterial species, including anaerobes that are usually poorly identified with current phenotypic methods, from stool specimens [34]. When a limited number of culture conditions commonly used in clinical microbiology laboratories were applied, all the isolated bacteria were present in the MALDI-TOF MS database, although some bacteria were poorly identified and needed further 16S rRNA or ITS sequencing.
Our study has some limitations. We used limited types of culture media commonly used in clinical microbiology laboratories. While picking the colonies from each agar plate, some bacteria may have been missed because of selection bias. The agar plates were incubated for only 48 hours; this duration may not have been adequate for slow-growing microorganisms. Although we tried to inoculate the samples as soon as possible and within 6 hours post collection, some anaerobic bacteria may have been lost during the prolonged oxygen exposure. The number of reads, ~10,000 per sample on an average in this study, may also affect the bacterial species detected in each sample. Most of the bacterial species were successfully identified using MALDI-TOF MS. However, the reliability of streptococci identification might not be high because of the inherent limitations of MALDI-TOF MS. Lastly, we did not quantify the microorganisms in in culture method, which is a limitation in exploring microbial diversity.
To the best of our knowledge, this is the first study to evaluate the use of conventional culture methods combined with MALDI-TOF MS in microbiome analysis of BAL fluid samples compared with 16S rRNA NGS. Some bacteria, mainly anaerobes, failed to grow on conventional culture media, and less diverse microbial communities were identified with the culture method. However, interestingly, some common bacteria were not identified by sequencing, but were cultured, indicating the significance of culture in microbiome analysis. Despite a number of limitations, culture methods with MALDI-TOF MS may play a significant role in microbiome analysis that is complementary to 16S rRNA NGS.

Notes

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Acknowledgments

This work was supported by the National Research Foundation of Korea (2014M3A9E5073818), the BioNano Health-Guard Research Center funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea as a Global Frontier Project (H-GUARD_2014M3A6B2060509), and the Ministry of Health & Welfare, Republic of Korea (HI14C1324).

References

1. Twigg HL 3rd, Morris A, Ghedin E, Curtis JL, Huffnagle GB, Crothers K, et al. Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise. Lancet Respir Med. 2013; 1:354–356. PMID: 24429191.
2. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011; 184:957–963. PMID: 21680950.
3. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One. 2011; 6:e16384. PMID: 21364979.
4. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 185:1073–1080. PMID: 22427533.
5. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013; 187:1067–1075. PMID: 23491408.
6. Hamady M, Knight R. Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res. 2009; 19:1141–1152. PMID: 19383763.
7. Allen-Vercoe E. Bringing the gut microbiota into focus through microbial culture: recent progress and future perspective. Curr Opin Microbiol. 2013; 16:625–629. PMID: 24148301.
8. Sommer MO. Advancing gut microbiome research using cultivation. Curr Opin Microbiol. 2015; 27:127–132. PMID: 26401902.
9. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A. 2011; 108:6252–6257. PMID: 21436049.
10. Lagier JC, Armougom F, Million M, Hugon P, Pagnier I, Robert C, et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect. 2012; 18:1185–1193. PMID: 23033984.
11. Rettedal EA, Gumpert H, Sommer MO. Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria. Nat Commun. 2014; 5:4714. PMID: 25163406.
12. Brady C, Cleenwerck I, Venter S, Vancanneyt M, Swings J, Coutinho T. Phylogeny and identification of Pantoea species associated with plants, humans and the natural environment based on multilocus sequence analysis (MLSA). Syst Appl Microbiol. 2008; 31:447–460. PMID: 19008066.
13. Heikens E, Fleer A, Paauw A, Florijn A, Fluit AC. Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol. 2005; 43:2286–2290. PMID: 15872257.
14. Neuberger A, Oren I, Sprecher H. Clinical impact of a PCR assay for rapid identification of Klebsiella pneumoniae in blood cultures. J Clin Microbiol. 2008; 46:377–379. PMID: 17942663.
15. Liu Z, Lozupone C, Hamady M, Bushman FD, Knight R. Short pyrosequencing reads suffice for accurate microbial community analysis. Nucleic Acids Res. 2007; 35:e120. PMID: 17881377.
16. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011; 27:2194–2200. PMID: 21700674.
17. Kim OS, Cho YJ, Lee K, Yoon SH, Kim M, Na H, et al. Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol. 2012; 62:716–721. PMID: 22140171.
18. Charlson ES, Bittinger K, Chen J, Diamond JM, Li H, Collman RG, et al. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One. 2012; 7:e42786. PMID: 22970118.
19. Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio. 2015; 6:e00037. PMID: 25736890.
20. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014; 12:87. PMID: 25387460.
21. Walker AW, Martin JC, Scott P, Parkhill J, Flint HJ, Scott KP. 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome. 2015; 3:26. PMID: 26120470.
22. Davis IJ, Bull C, Horsfall A, Morley I, Harris S. The Unculturables: targeted isolation of bacterial species associated with canine periodontal health or disease from dental plaque. BMC Microbiol. 2014; 14:196. PMID: 25085267.
23. Ohno M, Okano I, Watsuji T, Kakinuma T, Ueda K, Beppu T. Establishing the independent culture of a strictly symbiotic bacterium Symbiobacterium thermophilum from its supporting Bacillus strain. Biosci Biotechnol Biochem. 1999; 63:1083–1090. PMID: 10427695.
24. Hiergeist A, Glasner J, Reischl U, Gessner A. Analyses of Intestinal Microbiota: Culture versus Sequencing. ILAR J. 2015; 56:228–240. PMID: 26323632.
25. Maukonen J, Simoes C, Saarela M. The currently used commercial DNA-extraction methods give different results of clostridial and actinobacterial populations derived from human fecal samples. FEMS Microbiol Ecol. 2012; 79:697–708. PMID: 22098067.
26. Willner D, Daly J, Whiley D, Grimwood K, Wainwright CE, Hugenholtz P. Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samples. PLoS One. 2012; 7:e34605. PMID: 22514642.
27. Kennedy NA, Walker AW, Berry SH, Duncan SH, Farquarson FM, Louis P, et al. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PLoS One. 2014; 9:e88982. PMID: 24586470.
28. Beck JM. ABCs of the lung microbiome. Ann Am Thorac Soc. 2014; 11(Suppl 1):S3–S6. PMID: 24437402.
29. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005; 308:1635–1638. PMID: 15831718.
30. Zoetendal EG, Vaughan EE, de Vos WM. A microbial world within us. Mol Microbiol. 2006; 59:1639–1650. PMID: 16553872.
31. Fournier PE, Lagier JC, Dubourg G, Raoult D. From culturomics to taxonomogenomics: a need to change the taxonomy of prokaryotes in clinical microbiology. Anaerobe. 2015; 36:73–78. PMID: 26514403.
32. Lagier JC, Hugon P, Khelaifia S, Fournier PE, La Scola B, Raoult D. The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev. 2015; 28:237–264. PMID: 25567229.
33. Lagier JC, Million M, Hugon P, Armougom F, Raoult D. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol. 2012; 2:136. PMID: 23130351.
34. Samb-Ba B, Mazenot C, Gassama-Sow A, Dubourg G, Richet H, Hugon P, et al. MALDI-TOF Identification of the Human Gut Microbiome in People with and without Diarrhea in Senegal. Plos One. 2014; 9:e87419. PMID: 24784934.
Fig. 1

Number of the operational taxonomic units and genera identified by culture and 16S rRNA next generation sequencing analysis.

alm-38-110-g001
Fig. 2

Bacterial genera identified using culture with/without sequencing and 16S rRNA next generation sequencing analysis.

alm-38-110-g002
Table 1

Primers used for 16s rRNA and ITS PCR and sequencing

alm-38-110-i001
Primers Sequences (5'-3') Target
27F GAGTTTGATCMTGGCTCAG Universal bacteria [32]
518R WTTACCGCGGCTGCTGG
27F AGAGTTTGATCMTGGCTCAG Universal bacteria [32]
1492R TACGGYTACCTTGTTACGACTT
ITS4_F TCCGTAGGTGAACCTGCGG Universal fungus [33]
ITS4_R TCCTCCGCTTATTGATATGC
tuf_F GCCAGTTGAGGACGTATTCT Staphylococcus [13]
tuf_R CCATTTCAGTACCTTCTGGTAA
Hemolysin_F CGACCTGATTGCATTCGCCAC Klebsiella modified from [14]
Hemolysin_R TGGTCAACCCAACGATCCTG
rpoB_F CAGGTCGTCACGGTAACAAG Enterobacter [12]
rpoB_F GTGGTTCAGTTTCAGCATGTAC
Table 2

Number of bacterial and fungal colonies on the culture media, identified by MALDI-TOF MS

alm-38-110-i002
BAP MAC CHO BRU PE SDA Total
Actinomyces gravenitzii 0 0 4 7 0 0 11
Actinomyces odontolyticus 1 0 14 20 17 0 52
Actinomyces oris 6 0 2 0 1 0 9
Bacillus badius 0 0 0 2 0 0 2
Bifidobacterium dentium 0 0 0 0 1 0 1
Bifidobacterium longum 0 0 0 0 2 0 2
Clostridium difficile 0 0 0 5 10 0 15
Corynebacterium argentoratense 6 0 6 0 0 0 12
Corynebacterium durum 2 0 0 0 0 0 2
Corynebacterium pseudodiphtheriticum 0 0 2 0 0 0 2
Escherichia coli 0 1 0 0 0 0 1
Fusobacterium canifelinum 0 0 0 1 0 0 1
Fusobacterium gonidiaformans 0 0 0 0 1 0 1
Fusobacterium nucleatum 0 0 0 1 0 0 1
Fusobacterium periodonticum 0 0 0 6 1 0 7
Enterobacter aerogenes 22 39 12 4 0 29 106
Enterobacter cloacae 2 0 0 0 0 0 2
Granulicatella adiacens 0 0 4 0 0 0 4
Gemella haemolysans 1 0 0 0 3 0 4
Gemella morbillorum 1 0 0 2 2 0 5
Gemella sanguinis 2 0 1 4 2 0 9
Megasphaera micronuciformis 0 0 0 3 0 0 3
Klebsiella oxytoca 4 21 4 0 0 15 44
Klebsiella pneumoniae 7 40 7 18 0 5 77
Lactobacillus fermentum 0 0 2 0 0 3 5
Lactobacillus plantarum 0 0 0 0 0 1 1
Lactobacillus salivarius 0 0 2 0 0 2 4
Leuconostoc citreum 0 0 0 0 0 3 3
Micrococcus luteus 2 0 0 2 0 0 4
Neisseria bacilliformis 2 0 0 0 0 0 2
Neisseria cinerea 2 0 0 0 0 0 2
Neisseria elongate 1 0 0 0 0 0 1
Neisseria flavescens 92 0 69 1 0 0 162
Neisseria macacae 10 0 8 0 0 0 18
Neisseria meningitidis 0 0 1 0 0 0 1
Neisseria mucosa 15 0 2 0 0 0 17
Neisseria perflava 27 0 10 0 0 0 37
Neisseria sicca 2 0 0 0 0 0 2
Neisseria subflava 15 0 21 0 0 0 36
Neisseria spp. 4 0 6 0 0 1 11
Parvimonas micra 0 0 0 1 0 0 1
Peptostreptococcus anaerobius 0 0 0 14 0 0 14
Prevotella melaninogenica 0 0 0 2 2 0 4
Prevotella pallens 0 0 0 2 0 0 2
Propionibacterium acnes 0 0 0 0 1 0 1
Pseudomonas aeruginosa 2 3 2 0 0 0 7
Rothia aeria 2 0 0 0 0 0 2
Rothia dentocariosa 25 0 12 0 0 0 37
Rothia mucilaginosa 75 0 41 0 1 4 121
Staphylococcus aureus 9 0 11 5 6 8 39
Staphylococcus epidermidis 3 0 2 15 0 3 23
Staphylococcus hominis 0 0 0 0 0 2 2
Staphylococcus warneri 0 0 3 1 0 0 4
Streptococcus agalactiae 0 0 0 1 0 0 1
Streptococcus anginosus 3 0 2 1 17 0 23
Streptococcus constellatus 0 0 1 6 12 0 19
Streptococcus cristatus 1 0 0 2 0 0 3
Streptococcus dentriousetti 0 0 1 0 0 0 1
Streptococcus gordonii 2 0 0 2 2 0 6
Streptococcus hominis 0 0 0 0 0 1 1
Streptococcus infantis 1 0 1 1 0 0 3
Streptococcus intermedius 0 0 0 0 2 0 2
Streptococcus mitis 10 0 6 11 14 0 41
Streptococcus oralis 7 0 4 16 6 0 33
Streptococcus parasanguinis 58 0 7 76 149 8 298
Streptococcus pasteuri 0 0 1 0 0 0 1
Streptococcus pectoris 7 0 1 10 7 0 25
Streptococcus pneumoniae 18 0 2 68 34 1 123
Streptococcus pyogenes 0 0 0 3 1 0 4
Streptococcus salivarius 59 0 146 66 158 163 592
Streptococcus sanguinis 5 0 7 2 5 0 19
Streptococcus sobrinus 0 0 1 0 0 0 1
Streptococcus vestibularis 4 0 9 1 3 0 17
Haemophilus influenzae 0 0 1 0 0 0 1
Haemophilus parahaemolyticus 0 0 3 0 0 0 3
Haemophilus parainfluenzae 1 0 33 6 0 0 40
Veillonella atypica 0 0 0 30 6 0 36
Veillonella dispar 0 0 0 18 3 0 21
Veillonella parvula 0 0 0 11 1 0 12
Veillonella salivarius 0 0 0 0 0 0 0
Veillonella spp. 0 0 0 2 1 0 3
Aspergillus fumigatus 0 0 0 0 0 5 5
Candida albicans 0 0 1 0 0 1 2
Candida glabrata 0 0 0 0 0 0 0
Total 518 104 475 449 471 255 2,272

Abbreviations: BAP, Blood agar plate; MAC, MacConkey agar plate; CHO, Chocolate agar plate; BRU, Brucella agar plate; PE, Phenylethyl alcohol agar plate; SDA, Sabouraud dextrose agar plate.

Table 3

Microbial genera identified solely by culture and not by 16S rRNA next generation sequencing analysis

alm-38-110-i003
Genus Number of samples (%)
Staphylococcus 8 (20.5)
Clostridium 7 (17.9)
Aspergillus 5 (12.8)
Klebsiella 4 (10.3)
Bifidobacterium 3 (7.7)
Candida 2 (5.1)
Enterobacter 2 (5.1)
Bacillus 1 (2.6)
Corynebacterium 1 (2.6)
Escherichia 1 (2.6)
Lactobacillus 1 (2.6)
Leuconostoc 1 (2.6)
Micrococcus 1 (2.6)
Pseudomonas 1 (2.6)
Slackia 1 (2.6)
TOOLS
Similar articles